Fine-Tuning the Treatment Algorithm in Advanced Head and Neck Cancer
WebcastFaculty
OVERVIEW
Fine-Tuning the Treatment Algorithm in Advanced Head and Neck Cancer is organized by PRIME Oncology and will be held during Oct 13, 2017 - Oct 13, 2018.
The target audience for this medical event is specifically designed for medical oncologists, radiation oncologists, head and neck surgeons, and other healthcare professionals involved in the treatment of patients with head and neck cancer.
Course Description :
Get insights from the head and neck squamous cell cancer (HNSCC) experts on treatment options for advanced HNSCC, including combination therapies and immunotherapies. Watch the videos, download the slides, and impact your practice.
Topics:
• The evolving treatment algorithm for advanced HNSCC
• Scenario #1—Locally advanced HNSCC: Options for cisplatin-ineligible patients
• Scenario #2—Recurrent/metastatic HNSCC: Front-line therapy and beyond
• Scenario #3—Progression on immunotherapy in recurrent/metastatic HNSCC prIME Points
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Explain multidisciplinary approaches for managing HPV+ and HPV- locally advanced HNSCC
• Select an optimal treatment sequence for patients with recurrent/metastatic HNSCC
• Evaluate therapeutic options for advanced HNSCC after progression on immunotherapy and identify ongoing research strategies in advanced HNSCC, including combinations of conventional therapies and immunotherapies
Additional details will be posted as soon as they are available.
The target audience for this medical event is specifically designed for medical oncologists, radiation oncologists, head and neck surgeons, and other healthcare professionals involved in the treatment of patients with head and neck cancer.
Course Description :
Get insights from the head and neck squamous cell cancer (HNSCC) experts on treatment options for advanced HNSCC, including combination therapies and immunotherapies. Watch the videos, download the slides, and impact your practice.
Topics:
• The evolving treatment algorithm for advanced HNSCC
• Scenario #1—Locally advanced HNSCC: Options for cisplatin-ineligible patients
• Scenario #2—Recurrent/metastatic HNSCC: Front-line therapy and beyond
• Scenario #3—Progression on immunotherapy in recurrent/metastatic HNSCC prIME Points
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Explain multidisciplinary approaches for managing HPV+ and HPV- locally advanced HNSCC
• Select an optimal treatment sequence for patients with recurrent/metastatic HNSCC
• Evaluate therapeutic options for advanced HNSCC after progression on immunotherapy and identify ongoing research strategies in advanced HNSCC, including combinations of conventional therapies and immunotherapies
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links